Skip to main content
Caplight Logo









NG Bio

NG Bio

Overview

NG Bio is a venture capital firm and venture builder that invests in early-stage companies focused on immunology and inflammatory diseases to extend human health span and longevity.

Year Founded

2020

Portfolio Companies

2

Investments

NG Bio investments
CompanyDateStageLead
LightOx LtdOct 2021SeedCo-investor
AbselionApr 2021SeedCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is NG Bio based?

NG Bio is headquartered in London, United Kingdom.

When was NG Bio founded?

NG Bio was founded in 2020.

How many portfolio companies does NG Bio have?

NG Bio has 2 portfolio companies in Caplight's dataset.

What are some companies in NG Bio's portfolio?

Portfolio companies visible on Caplight include LightOx Ltd, Abselion.

What was NG Bio's most recent investment shown here?

NG Bio's most recent investment in this portfolio sample was in LightOx Ltd in 2021.

What sectors does NG Bio focus on?

NG Bio focuses on Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences.

What company stages does NG Bio focus on?

NG Bio typically invests at the Early stage.

Firmographic Details

HeadquartersLondon
Year Founded2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?